Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.
Eur J Microbiol Immunol (Bp)
; 2024 May 16.
Article
in En
| MEDLINE
| ID: mdl-38753442
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Eur J Microbiol Immunol (Bp)
Year:
2024
Document type:
Article
Affiliation country:
Irán
Country of publication:
Hungria